Description
Clinical Publishing Year In Dyslipidaemia 2004 by P. Durrington , M.I. Mackness , J.P. Miller , J.A.E. Rees
Exploring the most up to date information in the peer-reviewed literature, The Year in Dyslipidaemia 2004 presents an overview of the latest advancements in this complex field. The editors scan nearly 50 journals, reviews and summarize their most significant papers, and place them in context. This process of distillation provides the reader with an invaluable reference. The book covers the different modifiable risk factors and the increase in propensity for cardiovascular disease caused by type 2 diabetes. Providing a guide to these possibilities, it keeps the specialist or GP up to date with the ever-increasing range of therapeutic and prophylactic options available for the management of lipid disorders. LIPID DISORDERS, P. MillerPrimary HypercholesterolaemiaHypertriglyceridaemia and Mixed HyerlipidaemiaSecondary Hyperlipidaemia: Renal Disease and Transplant DyslipidaemiaDIABETES AND DYSLIPIDAEMIA, A. Rees and M. EvansDiabetic Dislipidaemia and Coronary DiseaseType 2 Diabetes, Metabolic Syndrome, and InflammationLIPIDS AND ATHERSCLEROSIS, M. Mackness, P. Holvet, and M. CaslakeNon-Lipid-Lowering Effects of StatinsHigh-Density Lipoprotein and AtherosclerosisAntioxidants and AtherosclerosisOxidized Low-Density Lipoprotein and AtherosclerosisClinical ChemistryAnimal Models of AtherosclerosisGene Therapy for AtherosclerosisLIPID-LOWERING TRIALS, P. DurringtonTrials with Clinical End-PointsClinical Trials in the Context of Epidemiology and Clinical PracticeTrials of Therapy to Modify Serum Lipids and LipoproteinsEffect of Lipid-Lowering Drugs on Non-Coronary Disease